HIGHLIGHTS
- who: Namsoo Kim from the National Institutes of Health (NIH), United States Thammasat University, Thailand have published the paper: Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer, in the Journal: (JOURNAL)
- what: Compared with these studies, the study showed a moderate sensitivity of 66.7% and a high specificity of 100%.
- how: The authors investigated the feasibility of genomic profiling based on tumor DNA analysis from cervical smear samples from endometrial cancer patients. Acquisition of cell-free DNA and nextgeneration sequencing For tumor gDNA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.